Schreiber 2014.

Methods	Design: randomized; open label; mixed methods Location: Philadelphia PA (USA) Time frame: April 2011 to October 2012 Sample size estimation and outcome of focus: no information
Participants	100 women Inclusion criteria: English‐speaking; age 18 to 45 years; immediately postpartum of live singleton infant, 37 weeks gestation; desire to delay another pregnancy for next 6 months; willing and able to follow protocol Exclusion criteria: breastfeeding; plans to relocate outside of Philadelphia area in next 6 months; plans for use of weight loss medication or diet pills in next 6 months; wish to use Implanon or DMPA prior to discharge but does not want to be randomized
Interventions	1) DepoProvera (DMPA) 150 mg 2) Implanon; 68 mg etonogestrel 3) Control: select own method of contraception or no contraception
Outcomes	Primary: weight change by 6 months postpartum Secondary: pregnancy; contraception satisfaction Follow‐up: 3, 6, and 12 months postpartum
Notes	Will consider for inclusion when full report is available

BMI: body mass index
 DMPA: depot medroxyprogesterone acetate
 LNG‐IUC: levonorgestrel‐releasing intrauterine contraception
 POP: progestin‐only oral pills